MBX Biosciences Inc (NASDAQ: MBX) on Tuesday, plunged -8.63% from the previous trading day, before settling in for the closing price of $31.39. Within the past 52 weeks, MBX’s price has moved between $4.81 and $34.83.
The company achieved an average annual earnings per share of 55.83%. With a float of $26.48 million, this company’s outstanding shares have now reached $44.72 million.
MBX Biosciences Inc (MBX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of MBX Biosciences Inc is 41.02%, while institutional ownership is 68.57%. The most recent insider transaction that took place on Oct 20 ’25, was worth 272,790. In this transaction President & CEO of this company bought 20,000 shares at a rate of $13.64, taking the stock ownership to the 468,277 shares. Before that another transaction happened on Oct 17 ’25, when Company’s Director bought 20,000 for $13.25, making the entire transaction worth $264,984. This insider now owns 20,000 shares in total.
MBX Biosciences Inc (MBX) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.47 earnings per share (EPS) for the period topping the consensus outlook (set at -0.59) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.75 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 55.83% per share during the next fiscal year.
MBX Biosciences Inc (NASDAQ: MBX) Trading Performance Indicators
MBX Biosciences Inc (MBX) is currently performing well based on its current performance indicators. A quick ratio of 32.95 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.39, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -3.01 in one year’s time.
Technical Analysis of MBX Biosciences Inc (MBX)
MBX Biosciences Inc (NASDAQ: MBX) saw its 5-day average volume 1.08 million, a positive change from its year-to-date volume of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 40.22%.
During the past 100 days, MBX Biosciences Inc’s (MBX) raw stochastic average was set at 75.60%, which indicates a significant increase from 30.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.48 in the past 14 days, which was higher than the 1.70 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.34, while its 200-day Moving Average is $14.05. Nevertheless, the first resistance level for the watch stands at $30.91 in the near term. At $33.14, the stock is likely to face the second major resistance level. The third major resistance level sits at $34.33. If the price goes on to break the first support level at $27.50, it is likely to go to the next support level at $26.31. The third support level lies at $24.08 if the price breaches the second support level.
MBX Biosciences Inc (NASDAQ: MBX) Key Stats
Market capitalization of the company is 1.29 billion based on 44,902K outstanding shares. Right now, sales total 0 K and income totals -61,920 K. The company made 0 K in profit during its latest quarter, and -21,620 K in sales during its previous quarter.
